SCHEMBL4029830

SCHEMBL4029830

CCn1c2c(c3cc(C(=O)OC)ccc31)CC(C)(C)CC2

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ SCARB1 Q8WTV0 2/20 0.46
▸ KDM4E B2RXH2 3/20 0.45
▸ RORC P51449 2/20 0.43
▸ HSD17B10 Q99714 3/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ TSHR P16473 2/20 0.42
▸ HPGD P15428 1/20 0.42
▸ PTGER4 P35408 5/20 0.41
▸ CNR1 P21554 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ MAPKAPK2 P49137 1/20 0.38
▸ CNR2 P34972 1/20 0.37
▸ ACSS2 Q9NR19 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4024468 0.87 ALDH1A1 (0.55) KDM4ERORCHSD17B10ALDH1A1TSHR
SCHEMBL6756508 0.82 SCARB1 (0.63) SCARB1KDM4ERORCHSD17B10ALDH1A1
SCHEMBL4209635 0.80 MAOA (0.48) KDM4EHSD17B10ALDH1A1PTGER4MEN1
SCHEMBL13746711 0.79 KMT2A (0.47) KDM4ERORCALDH1A1HPGDMEN1
SCHEMBL4023279 0.79 SCARB1 (0.49) SCARB1KDM4EALDH1A1HPGDMAPKAPK2
SCHEMBL4195183 0.77 SCARB1 (0.52) SCARB1KDM4EHSD17B10MAPKAPK2CNR2
SCHEMBL22511693 0.74 RORC (0.56) SCARB1KDM4ERORCHSD17B10ALDH1A1
SCHEMBL4199593 0.73 SCARB1 (0.38) SCARB1KDM4ERORCHSD17B10ALDH1A1
SCHEMBL4728729 0.71 PTGER4 (0.69) SCARB1KDM4ERORCALDH1A1HPGD
SCHEMBL541347 0.70 AKR1B10 (0.61) KDM4EHSD17B10ALDH1A1HPGDPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009103022-A1 DERIVATIVES OF SUBSTITUTED FUSED RING CYCLOINDOLES AND METHODS OF THEIR USE ITHERX PHARMACEUTICALS, INC. (US) 2009-08-20 — — WO disclosed
WO-2008021745-A2 HEPATITIS C VIRUS ENTRY INHIBITORS ITHERX PHARMACEUTICALS, INC. (US) 2008-02-21 — — WO disclosed
Send feedback